Disease Markers · 2019 · 18 citations · 23 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyProteomicsCancer BiomarkersCancer ProteomicsMetastatic Breast CancerMolecular Tumor ProfilingProteomic BiomarkersTumor MarkersBiomarker DetectionBreast Cancer PrognosisCancer Metastasis BiomarkersLymph Node MetastasesLymph Node Metastasis BiomarkersPrognostic BiomarkersSecreted Frizzled-related ProteinsTnm Staging System
Purpose . Secreted frizzled-related protein 2 (sFRP2) is a secreted protein associated with cancer drug resistance and metastasis. However, few studies have reported serum sFRP2 levels in breast cancer. We evaluated serum sFRP2 as a potential biomarker for breast cancer. Methods . Serum sFRP2 concentrations were detected in 274 breast cancer patients along with 147 normal healthy controls by enzyme-linked immunosorbent assay (ELISA). Diagnostic significance was evaluated by area under the curve (AUC) analysis and the Youden index. Prognostic significance was determined by Kaplan-Meier survival method and univariate and multivariate Cox proportional hazard regression model analyses. Results . Serum sFRP2 was elevated in breast cancer patients compared to normal healthy controls (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:math>). The sensitivity of sFRP2 in diagnosing breast cancer was 76.9% at a specificity of 76.6%. Elevated serum sFRP2 levels are associated with primary tumor size, TNM stage, and lymph node metastases. The Kaplan-Meier curves showed a significant association of serum sFRP2 with progression-free survival. The multivariate Cox analysis confirmed that high serum sFRP2 was an independent prognostic factor for poor prognosis (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mtext>H</mml:mtext><mml:mtext>R</mml:mtext><mml:mo>=</mml:mo><mml:mn>3.89</mml:mn></mml:math>, 95% <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mtext>C</mml:mtext><mml:mtext>I</mml:mtext><mml:mo>=</mml:mo><mml:mn>1.95</mml:mn></mml:math>-7.68, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:math>). Conclusions . In conclusion, serum sFRP2 may serve as a potential biomarker for breast cancer diagnosis and prognostic evaluation.
23
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
SARPs: A family of secreted apoptosis-related proteins
Hovsep Melkonyan, Wei Chun Chang, John P. Shapiro et al. · Proceedings of the National Academy of Sciences · 1997 · 325 citations